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Background  
The human periodontium health is commonly compromised by inflammatory conditions, which are designated by 
periodontal diseases. Porphyromonas gingivalis is considered a keystone periodontal pathogen, capable of breaking the 
homeostatic relationship with the host and initiating an inflammatory disease. It is thought that the dysbiotic changes 
caused by this pathogen could be reversed by its specific removal, being an excellent target candidate for therapy. Due to 
limitations of the current therapies that often leads to the recurrence of the disease and the increasing bacterial resistance 
to antimicrobials, there is a need for novel approaches to control periodontal disease. Peptidoglycan hydrolases (PGHs) 
are lytic enzymes that cleave bonds in the bacterial peptidoglycan (PG). In contrast to the well-known bacteriophage-
encoded PGHs, such as endolysins, the exogenous use of bacterial-derived PGHs to control pathogenic bacteria remains 
poorly explored. In this work we explored the use of a P. gingivalis-encoded PGH against itself. 
 
Method  
An in silico analysis was carried out on the genome of P. gingivalis 2561 (GenBank AP009380.1) for the identification of 
putative PGHs. A probable N-acetylmuramoyl-L-alanine amidase, denominated by PgPALys, was cloned in the pET-28a 
expression vector and its expression in E. coli BL21 (DE3) and subsequent purification was optimized. The antibacterial 
activity of the recombinant protein (alone or in combination with the outer membrane permeabilizer EDTA) was assessed 
against P. gingivalis 2561 and P. gingivalis HG66 after incubation at 37 °C in the anaerobic chamber for up to 24 hours. 
 
Results & Conclusions  
Antibacterial assays demonstrated that PgPALys is active against P. gingivalis, reducing 1.08 ± 0.38 and 1.45 ± 0.37 
logarithm units of P. gingivalis 2561 and P. gingivalis HG66 cells after 24 hours of incubation, respectively. The well-known 
chelator EDTA was used in combination with PgPALys to increase the permeability of P. gingivalis outer membrane (OM) 
and thus enhance the antibacterial activity. Overall, the antibacterial activity of PgPALys/EDTA improved with the time, 
resulting in an inactivation of 2.03 ± 0.58 and 2.53 ± 0.71 logarithm units of 2561 and HG66 cells after 24 hours of 
contact. 
This work shows the potential of a P. gingivalis-encoded enzyme for the control of the aforementioned periodontal 
pathogen, providing new insights into the use of a bacterial-derived PGH for the control of bacterial diseases. 
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